Showing 1 of 1 recruiting trials for “Hepatocellular adenoma”
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
👨⚕️ Jean-Charles NAULT, PUPH, Assistance Publique des Hôpitaux de Paris (APHP)📍 1 site📅 Started Oct 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →